home / stock / gh / gh news

GH News and Press, Guardant Health Inc. From 05/24/24

Stock Information
Company Name: Guardant Health Inc.
Stock Symbol: GH
Market: NASDAQ
Website: guardanthealth.com
Menu
GH GH Quote GH Short GH News GH Articles GH Message Board
Get GH Alerts

News, Short Squeeze, Breakout and More Instantly...
GH - Buy Recommendation Issued On GH By Stephens

2024-05-24 21:15:02 ET Stephens analyst issues BUY recommendation for GH on May 24, 2024 05:00PM ET. The previous analyst recommendation was Buy. GH was trading at $25.52 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst rec...
GH - Underperform Recommendation Issued On GH By Piper Sandler

2024-05-24 21:15:01 ET Piper Sandler analyst issues UNDERPERFORM recommendation for GH on May 24, 2024 05:00PM ET. The previous analyst recommendation was Underperform. GH was trading at $25.52 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...

GH - Guardant jumps as trading resumes after FDA AdCom vote on cancer test

2024-05-24 09:25:08 ET More on Guardant Health Guardant Health, Inc. (GH) Q1 2024 Earnings Call Transcript Guardant Health: Shield Launch Could Drive Multiple Expansion Guardant Health colorectal cancer screening test endorsed by FDA advisors Guardant shares ...

GH - FDA Advisory Committee Panel Strongly Recommends Approval of Shield(TM) Blood Test for Colorectal Cancer Screening as a Primary Non-Invasive Screening Option

The advisory committee offers valuable non-binding recommendations for the FDA Blood test offers a convenient non-invasive screening option that overcomes barriers associated with current non-invasive screening tests Shield remains on track to become the first FDA-approved blood t...
GH - Guardant Health colorectal cancer screening test endorsed by FDA advisors

2024-05-23 17:05:39 ET More on Guardant Health Guardant Health slips as FDA comments on cancer screening test Guardant Health: Shield Launch Could Drive Multiple Expansion Guardant Health, Inc. (GH) Q1 2024 Earnings Call Transcript Seeking Alpha’s Quan...

GH - Guardant shares on hold for trading ahead of AdCom meeting on cancer test

2024-05-23 08:39:07 ET More on Guardant Health Guardant Health, Inc. (GH) Q1 2024 Earnings Call Transcript Guardant Health: Shield Launch Could Drive Multiple Expansion Guardant Health slips as FDA comments on cancer screening test Guardant Health Non-GAAP EP...

GH - Guardant Health Stock Trading Temporarily Halted; FDA Panel to Assess Premarket Approval Application for Shield Blood Test for Colorectal Cancer Screening

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that Nasdaq has temporarily halted trading of the company's stock. The Molecular and Clinical Genetics Panel of the U.S. Food and Drug Administration (FDA) Medical Devices Advisory Committee will meet to...
GH - Guardant Health slips as FDA comments on cancer screening test

2024-05-21 11:05:08 ET More on Guardant Health Guardant Health, Inc. (GH) Q1 2024 Earnings Call Transcript Guardant Health: Shield Launch Could Drive Multiple Expansion Guardant Health, Inc. (GH) Q4 2023 Earnings Call Transcript Guardant Health Non-GAAP EPS o...

GH - Guardant Health Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications

Blood-based test for comprehensive genomic profiling of solid cancers meets requirements under stricter EU In Vitro Diagnostic Regulation IVDR certification from TÜV SÜD enables broader adoption of guideline-recommended genomic profiling to inform optimal therapy selection for p...

GH - SBRA, GH and CRBU are among after hour movers

2024-05-20 16:47:47 ET Gainers: Maravai LifeSciences  ( MRVI ) +5% . Caribou Biosciences ( CRBU ) +4% . Greenidge Generation Holdings  ( GREE ) +4% . Cipher Mining  ( CIFR ) +4% . SIGA Technologies  ( SIGA ) +4%...
Previous 10 Next 10